Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shexiang Baoxin Pill for CAD Not Amenable to Revascularization
NCT03072121Phase 4Unknown
- Start
- Jun 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of Shexiang Baoxin Pill in coronary artery disease (CAD). Status: unknown.
02
Drugs
Shexiang Baoxin Pill
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03072121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03072121.